EBR Systems, Inc., developer of the world’s only leadless left ventricular endocardial pacing (LVEP) system for heart failure, today announced its participation in the Heart Rhythm 2026 conference, ...

On March 12, 2026, the first implant of the ProStyle M(R) Transcatheter Mitral Valve System (ProStyle M(R) ) was successfully completed under pure ultrasound guidance as part of its confirmatory ...

KingstronBio announced today that it completed the first implant of its ProStyle M transcatheter mitral valve replacement ...

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...

KingstronBio takes innovation as its core driving force and has long been deeply engaged in the heart valve field. The ...

Adagio Medical Holdings Inc. (NASDAQ:ADGM) said it has received Investigational Device Exemption (IDE) authorization from the ...

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.

WASHINGTON — Scientists created virtual replicas of patients’ diseased hearts so precise that blocking a dangerous irregular heartbeat in these digital “twins” showed doctors how to better treat the r ...

LAGUNA HILLS, Calif., March 19, 2026--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment ...

Transcriptomic Profiling Reveals Antifibrotic effect of Cannabidiol through Epithelial/Endothelial-to-Mesenchymal Transition inhibition in a Murine Non-Ischemic Heart Failure Model Receive the the ...